This peptide has an amino acid sequence that mimics the lipolytic region of human growth hormone (the region of this hormone thought to be responsible for burning fat) and it has been promoted variously as a weight loss supplement, as an aid to muscle and cartilage repair, and a treatment for osteoarthritis by its manufacturers
The inclusion of semaglutide as an eligible expense for HSA/FSA holders marks a significant milestone in healthcare finance
Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure
If GLP-1 use continues to rise as expected, we may be able to see positive trends in alcohol-related public health statistics in the next 2-4 years
They support the insulin sensitivity that a lifetime of processed food has eroded
CMS has completed two negotiation cycles so far: the first set of 10 drugs took effect in 2026, and a second set of 15 drugs, including Ozempic and Wegovy, takes effect in 2027.